Bill Sponsor
House Bill 5160
119th Congress(2025-2026)
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Introduced
Introduced
Introduced in House on Sep 4, 2025
Overview
Text
Introduced
Sep 4, 2025
Latest Action
May 21, 2026
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5160
Congress
119
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary
Unavailable
Text (1)
September 4, 2025
Actions (7)
05/21/2026
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
05/21/2026
Committee Consideration and Mark-up Session Held
05/13/2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
05/13/2026
Subcommittee Consideration and Mark-up Session Held
09/04/2025
Referred to the Subcommittee on Health.
09/04/2025
Referred to the House Committee on Energy and Commerce.
09/04/2025
Introduced in House
Public Record
Record Updated
Jun 2, 2026 1:02:50 PM